Lixte Biotechnology Holdings, Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

1.220

+0.025 (2.09%)

Apr 2, 2025, 4:00 PM EDT - Market closed

LIXT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-3.59	-5.09	-6.31	-6.73	-3.26	Upgrade
Stock-Based Compensation	0.42	0.77	1.55	2.6	1.25	Upgrade
Change in Accounts Payable	-0.07	-0.07	0	0.04	0.05	Upgrade
Change in Unearned Revenue	0.08	-0.01	0.09	0.06	-0.08	Upgrade
Change in Other Net Operating Assets	-0	0.1	0.06	-0.11	-0.09	Upgrade
Operating Cash Flow	-3.16	-4.29	-4.61	-4.14	-2.13	Upgrade
Issuance of Common Stock	-	3.51	5.14	3.91	5.7	Upgrade
Other Financing Activities	-	-0.36	-	-0.01	-1.1	Upgrade
Financing Cash Flow	-	3.14	5.14	3.9	4.6	Upgrade
Net Cash Flow	-3.16	-1.15	0.53	-0.25	2.47	Upgrade
Cash Interest Paid	0.02	0.02	0.01	0.01	0	Upgrade
Levered Free Cash Flow	-1.82	-2.4	-2.25	-1.63	-0.9	Upgrade
Unlevered Free Cash Flow	-1.81	-2.39	-2.24	-1.63	-0.9	Upgrade
Change in Net Working Capital	-0	-0.02	-0.15	0.02	0.11	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q